Back to ACRS

WELLINGTON MANAGEMENT GROUP LLP → ACRS

WELLINGTON MANAGEMENT GROUP LLP ACRS Position History

Aclaris Therapeutics, Inc. • Healthcare

Quarters held
12
Latest value
$1.3M
Q3 2026
Peak value
$1.3M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$227K
Q4 2025$36K
Q4 2025$533K
Q1 2026$295K
Q1 2026$46K
Q1 2026$623K
Q2 2026$448K
Q2 2026$59K
Q2 2026$908K
Q3 2026$798K
Q3 2026$128K
Q3 2026$1.3M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$1.3M251.0K——
Q3 2026$128K24.3K——
Q3 2026$798K151.6K——
Q2 2026$908K171.6K——
Q2 2026$59K11.1K——
Q2 2026$448K84.7K——
Q1 2026$623K166.2K——
Q1 2026$46K12.2K——
Q1 2026$295K78.8K——
Q4 2025$533K177.1K——
Q4 2025$36K11.8K——
Q4 2025$227K75.4K——

Other funds holding ACRS

Other WELLINGTON MANAGEMENT GROUP LLP positions

NVDA

NVIDIA CORPORATION

$23.3B
MSFT

MICROSOFT CORP

$23.2B
NVDA

NVIDIA CORPORATION

$22.3B
NVDA

NVIDIA CORPORATION

$20.9B
MSFT

MICROSOFT CORP

$20.4B
NVDA

NVIDIA CORPORATION

$20B
AAPL

APPLE INC

$18.2B
AAPL

APPLE INC

$18.2B